Earnings release · ELV
ELEVANCE HEALTH REPORTS THIRD QUARTER 2026 RESULTS
Elevance Health, Inc. · Filed · SEC Form 8-K, Item 2.02
Revenue
$50.4 billion
+0.7% vs a year ago
EPS
$6.27
not detected
Guidance
raisedoutlook statement
Automated extract. The items below were picked out of the company's press release by software and may be wrong or incomplete.
Please read the original before relying on any figure. Not investment advice.
Why it matters
Revenue increased 0.7% year on year to $50.4 billion, and EPS was $6.27. Management raised its outlook, and guidance changes often matter more to the market than the quarter just reported because they reflect expectations for the periods ahead.
Written automatically by Stocknote's note engine from the figures on this page and the company's previous release. Every number in this note is checked against those figures. Not investment advice.
What the company states
Revenue
$50.4 billion +0.7% vs a year ago
…3Q 2026 operating revenue of $50.4 billion, up 0.7% from 3Q 2025…
EPS
$6.27
…3Q 2026 diluted EPS1 of $6.27 and adjusted diluted EPS2 of $6.99; results reflect improved operating performance and a net non-operating benefit…
Guidance
Guidance raised
…ELEVANCE HEALTH REPORTS THIRD QUARTER 2026 RESULTS; RAISES FULL-YEAR GUIDANCE…
Disclaimer: This page is generated automatically from public SEC filings for information only. Stocknote does not edit the company's release and does not guarantee the accuracy of the extracted items. Read the full disclaimer here.